Leede Financial Stock Recommendations and Price Targets

This is a list of recent ratings by Leede Financial.

Date	Company Name	Action	Current Price	Price Target	Rating
10/29/2025	EPRX Eupraxia Pharmaceuticals	Upgrade	$6.00		Strong-Buy
7/21/2025	PMN Promis Neurosciences	Upgrade	$8.00		Moderate Buy
1/22/2025	MDP Medexus Pharmaceuticals	Upgrade	C$3.00		Moderate Buy ➝ Strong-Buy
11/13/2024	ONCY Oncolytics Biotech	Downgrade	$1.00		Strong-Buy ➝ Moderate Buy
11/7/2024	DR Medical Facilities	Downgrade	C$16.00		Strong-Buy ➝ Hold
9/30/2024	MDP Medexus Pharmaceuticals	Set Price Target	C$3.00	C$8.25	Speculative Buy
9/13/2024	SVA Sernova	Lower Price Target	C$0.00	C$3.00 ➝ C$1.50	Speculative Buy
9/13/2024	CPH Cipher Pharmaceuticals	Downgrade	C$15.00		Strong-Buy ➝ Hold
8/22/2024	PHA Premier Health of America	Downgrade	C$0.00		Strong-Buy ➝ Moderate Buy